Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Website Related Posts Lobo Tiggre: Copper is My Highest-Confidence 2026 Trade, Uranium is Runner-Up November 8, 2025 Tech Weekly: Tech Stocks Feel the Heat Amid Valuation Fears November 8, 2025 Surface Metals Inc. Grants Options and Provides Update on Financial Marketing November 8, 2025